Eriocauline



Compound IDCDAMM02666
Common nameEriocauline
IUPAC name9-hydroxy-10-(9-hydroxy-7-methoxy-3-methyl-1-oxobenzo[g]isochromen-10-yl)oxy-7-methoxy-3-methylbenzo[g]isochromen-1-one
Molecular formulaC30H22O9

Experimental data

Retention time13.15
Adduct[2M+NH4]2+
Actual mz535.139
Theoretical mz535.143
Error8.06
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.1169

Identifiers and class information

Inchi keyAQBJYRSSNIUYNG-UHFFFAOYSA-N
SmilesO=C1OC(=CC=2C=C3C=C(OC)C=C(O)C3=C(OC=4C=5C(=O)OC(=CC5C=C6C=C(OC)C=C(O)C46)C)C12)C
SuperclassOrganoheterocyclic compounds
ClassNaphthopyrans

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)6
Number of reactive functional groups (#rtvFG)2
Predicted central nervous system activity (CNS)-1
Molecular weight (mol_MW)526.498
Computed dipole moment(dipole)1.059
Total solvent accessible surface area (SASA)767.217
Hydrophobic component of SASA (FOSA)377.099
Hydrophilic component of SASA (FISA)115.57
Pie component of the SASA (PISA)274.547
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1444.91
Number of hydrogen bond donors (donorHB)2
Number of hydrogen bond acceptors (accptHB)8.5
Free energy of solvation of dipole (dip^2/V)0.0007756
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0156681
Globularity descriptor (glob)0.805639
Predicted polarizability in cubic angstroms (QPpolrz)50.441
Predicted hexadecane/gas partition coefficient (QPlogPC16)14.855
Predicted octanol/gas partition coefficient (QPlogPoct)24.282
Predicted water/gas partition coefficient (QPlogPw)14.197
Predicted octanol/water partition coefficient (QPlogPo/w)4.199
Predicted aqueous solubility (QPlogS)-6.092
Conformation-independent predicted aqueous solubility (CIQPlogS)-8.138
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.986
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)794.238
Predicted brain/blood partition coefficient (QPlogBB)-0.985
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)385.664
Predicted skin permeability, log Kp (QPlogKp)-2.106
PM3 calculated ionization potential (IP(ev))8.064
PM3 calculated electron affinity (EA(eV))0.924
Number of likely metabolic reactions (#metab)6
Prediction of binding to human serum albumin (QPlogKhsa)0.594
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)90.477
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)125.761
Number of nitrogen and oxygen atoms (#NandO)9
Number of violations of Lipinski’s rule of five (RuleOfFive)1
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P21397MAOAMonoamine oxidase AT83875SEA
P43166CA7Carbonic anhydrase VIIT37541SEA
P27338MAOBMonoamine oxidase BT83011SEA
Q92731ESR2Estrogen receptor betaT80896SEA
P03372ESR1Estrogen receptor alphaT02506SEA
P09917ALOX5Arachidonate 5-lipoxygenaseT00140SEA
P60568IL2Interleukin-2T61698SEA
Q9UNQ0ABCG2ATP-binding cassette sub-family G member 2T56556SEA
Q16678CYP1B1Cytochrome P450 1B1T92521SEA
P16152CBR1Carbonyl reductase [NADPH] 1T70518SEA
Q15120PDK3Pyruvate dehydrogenase kinase isoform 3T99029SEA
O15427SLC16A3Monocarboxylate transporter 4T31788SEA
Q7RTX1TAS1R1Taste receptorT41263SEA
O35273SMAD3Mothers against decapentaplegic homolog 3T35445SEA
Q96HK3CALMCalmodulinT39610SEA
Q9UK17KCND3Voltage-gated potassium channel Kv4.3T74500SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T83875DI0117Depression[ICD-11: 6A70-6A7Z]P21397MAOA
T83875DI0331Parkinsonism[ICD-11: 8A00]P21397MAOA
T83011DI0115Dementia[ICD-11: 6D80-6D8Z]P27338MAOB
T83011DI0117Depression[ICD-11: 6A70-6A7Z]P27338MAOB
T83011DI0190Hypertension[ICD-11: BA00-BA04]P27338MAOB
T83011DI0243Malaria[ICD-11: 1F40-1F45]P27338MAOB
T83011DI0264Migraine[ICD-11: 8A80]P27338MAOB
T83011DI0331Parkinsonism[ICD-11: 8A00]P27338MAOB
T80896DI0062Breast cancer[ICD-11: 2C60-2C6Y]Q92731ESR2
T80896DI0108Cushing syndrome[ICD-11: 5A70]Q92731ESR2
T80896DI0254Menopausal disorder[ICD-11: GA30]Q92731ESR2
T80896DI0432Vasomotor/allergic rhinitis[ICD-11: CA08]Q92731ESR2
T02506DI0106COVID-19[ICD-11: 1D6Y]P03372ESR1
T00140DI0037Asthma[ICD-11: CA23]P09917ALOX5
T00140DI0147Filariasis[ICD-11: 1F66]P09917ALOX5
T00140DI0403Thrombocytopenia[ICD-11: 3B64]P09917ALOX5
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T56556DI0218Irritable bowel syndrome[ICD-11: DD91]Q9UNQ0ABCG2
T56556DI0366Rheumatoid arthritis[ICD-11: FA20]Q9UNQ0ABCG2
T70518DI0037Asthma[ICD-11: CA23]P16152CBR1
T41263DI0078Cholera[ICD-11: 1A00]Q7RTX1TAS1R1
T35445DI0226Kidney fibrosis[ICD-11: GC01]O35273SMAD3
T39610DI0068Cardiac arrhythmia[ICD-11: BC9Z]Q96HK3CALM
T39610DI0243Malaria[ICD-11: 1F40-1F45]Q96HK3CALM
T39610DI0370Schizophrenia[ICD-11: 6A20]Q96HK3CALM
T74500DI0004Acidosis[ICD-11: 5C73]Q9UK17KCND3

Copyright © 2025